Hempstract, Inc. (HPST)

0.0018 0.0000 (0.00%) At close: 10:00AM EDT

Hempstract, Inc.

PO Box 665
Warden, WA 98857-0665
United States

https://www.hempstractlabs.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 2

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Ronald M. Herzfeld	CEO & Director	N/A	N/A	N/A
Mr. Michael B. Glazer	Secretary	N/A	N/A	N/A
Ms. Linda Ellis	Vice President	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Hempstract, Inc. produces and sells cannabidiol (CBD) and cannabigerol solutions in the United States. It offers CBD isolate powder and distillate oil. The company was formerly known as Riverdale Oil and Gas Corporation and changed its name to Hempstract, Inc. in November 2020. Hempstract, Inc. is based in Warden, Washington.

Corporate governance

Hempstract, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.